Gritstone bio, Inc.
GRTSDelisted Mar 5, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001656634
Gritstone bio, Inc. was delisted on Mar 5, 2025; its insiders filed their last Form 4 on Apr 8, 2025; 56 institutions reported holding it in 13F filings for Q3 2024, worth $20.7M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Gritstone bio, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 92 | 115 | +23 |
| Shares | 42.4M | 49.1M | +6.71M (+15.8%) |
| Value | $458.4M | $630.0M | +$171.6M (+37.4%) |
New holders (34)
Institutions that held Gritstone bio, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
Sold out (11)
Institutions that held Gritstone bio, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| BVF Inc | 1,528,072 | $16.5M |
| Two Sigma Advisers, LP | 122,700 | $1.32M |
| DG Capital Management, LLC | 83,162 | $898.0K |
| Massachusetts Financial Services Co | 76,517 | $826.0K |
| Mirabella Financial Services LLP | 65,400 | $706.0K |
| DuPont Capital Management Corp | 51,229 | $553.0K |
| Gsa Capital Partners LLP | 40,303 | $435.0K |
| Engineers Gate Manager LP | 33,131 | $358.0K |
| Marshall Wace, LLP | 27,074 | $292.0K |
| Algert Global LLC | 18,958 | $205.0K |
| Blackstone Group Inc. | 8,761 | $95.0K |